This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Aimm Therapeutics B.v., Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 22 
1 out of 16 Years Active: 2020
Title: Inventor Marit Martha van Buuren: Pioneering T Cell Recognition Methods
Introduction
Marit Martha van Buuren is an innovative inventor based in Amsterdam, Netherlands. With a focus on advancing biomedicine, particularly in the field of immunology, she has contributed significantly to the understanding of T cell recognition through her patented work.
Latest Patents
Marit holds a patent for "Means and Methods for Determining T Cell Recognition." This invention provides improved screening methods for testing T cell recognition of T cell epitopes, which are crucial for the development of new immunotherapies.
Career Highlights
Throughout her career, Marit has collaborated with prominent institutions and companies. She has worked at Aimm Therapeutics B.V. and the Dutch Cancer Institute - Antoni van Leeuwenhoek Hospital, where her research has focused on groundbreaking approaches to cancer treatment.
Collaborations
Marit has had the privilege of working with talented individuals in her field, including Carsten Linnemann and Laura Bies. Their collective expertise has enhanced the development of innovative solutions to complex biomedical challenges.
Conclusion
Marit Martha van Buuren's contributions to the field of T cell recognition through her patent demonstrate her dedication to advancing medical research. Her collaborations and work at esteemed institutions strengthen the potential for new therapeutic advancements in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile